Related Experiment Video
Updated: Sep 13, 2025

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Risk Factors for Moderate-Severe Asthma in Children Ages 5-11 Years With Early-Onset Atopic Dermatitis
Robert S Zeiger1, Michael Schatz2, Botao Zhou3
1Department of Allergy, Kaiser Permanente Southern California (KPSC), San Diego, Calif; Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, Calif; Department of Research and Evaluation, KPSC, Pasadena, Calif.
Early childhood atopic dermatitis (AD) can predict moderate-severe persistent asthma (MS-Asthma). Factors like male sex, non-Hispanic Black ethnicity, and infections increase risk, while exclusive breastfeeding and maternal diabetes are protective.
Area of Science:
- Pediatric Allergy and Immunology
- Respiratory Medicine
- Epidemiology
Background:
- Identifying early childhood risk factors for persistent asthma is crucial for timely intervention.
- Early-onset atopic dermatitis (AD) is a known precursor to other atopic diseases, including asthma.
Purpose of the Study:
- To identify risk factors for developing moderate-severe persistent asthma (MS-Asthma) between ages 5-11 in children with early-onset AD.
- To develop predictive risk models for MS-Asthma using early childhood and maternal data.
Main Methods:
- A birth cohort of 10,688 children with AD onset before 36 months was analyzed using electronic health records up to age 11.
- MS-Asthma was defined as GINA step care level ≥3 for ≥4 years between ages 5-11.
- Robust Poisson regression was used to determine risk ratios for MS-Asthma.
Main Results:
- Children who developed MS-Asthma were more likely to be male, non-Hispanic Black, preterm, and not exclusively breastfed for one month.
- Significant risk factors included perinatal respiratory disorders, infections, food allergy, allergic rhinitis, asthma, sensitization, and elevated eosinophils.
- Maternal comorbidities, antibiotic use, and fewer pre-existing diabetes cases were associated with increased MS-Asthma risk. Protective factors included exclusive breastfeeding and maternal diabetes.
Conclusions:
- Risk models for later childhood MS-Asthma can be developed using early childhood and maternal factors from administrative data.
- Early identification of at-risk children with AD can facilitate targeted prevention and management strategies.
More Related Videos
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
Related Concept Videos
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...